Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 11.966
Filtrar
1.
Chin J Dent Res ; 27(2): 169-174, 2024 Jun 28.
Artículo en Inglés | MEDLINE | ID: mdl-38953482

RESUMEN

OBJECTIVE: To evaluate the effect of entrapment of curcumin within liposomal formulation and the sustained release attitude of the formulated liposomal gel on periodontal defects in diabetic patients in clinical and biochemical terms. METHODS: Thirty diabetic patients with periodontitis were randomly assigned to three equal groups and ten healthy participants were assigned as the control group. Group I was subjected to scaling and root planing (SRP) with application of sustained release liposomal curcumin gel. Group II was subjected to scaling and root planning with application of curcumin gel. Group III was subjected to scaling and root planning with application of placebo gel. Group IV (control group), no intervention was done. The following parameters were evaluated before treatment and after 6 and 12 weeks: plaque index (PI), gingival index (GI), probing depth (PD), clinical attachment level (CAL), tumour necrosis factor alpha (TNF-α), interleukin 1 beta (IL-1ß) and total antioxidant capacity (TAC). RESULTS: All study groups showed improvement in clinical and biochemical parameters that are statistically significant. Upon comparing the results of treatment modalities, the highest improvement was achieved in group I followed by group II then group III. CONCLUSION: Sustained release liposomal curcumin gel enhanced the antioxidant capacity, decreased the inflammatory mediators and showed more improvement in clinical outcome for treatment of periodontitis in diabetic patients.


Asunto(s)
Curcumina , Preparaciones de Acción Retardada , Liposomas , Humanos , Curcumina/uso terapéutico , Curcumina/administración & dosificación , Masculino , Femenino , Persona de Mediana Edad , Adulto , Raspado Dental , Periodontitis/tratamiento farmacológico , Aplanamiento de la Raíz , Resultado del Tratamiento , Factor de Necrosis Tumoral alfa , Antioxidantes/uso terapéutico , Antioxidantes/administración & dosificación , Índice Periodontal
2.
Int J Med Mushrooms ; 26(8): 1-11, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38967207

RESUMEN

Ganoderma lucidum is a medicinal mushroom that has been used since ancient times. We studied whether chronic oral administration of G. lucidum extract withstands increases in levels of proinflammatory TNF-α and lipid peroxide (LPO), an indicator of oxidative stress, in the gingival tissues of periodontitis model rats. G. lucidum extract was initially examined for inhibition of in vitro oxidative stress, produced by Fenton's reagents in whole homogenates of fresh gum tissues from rats. Prior to in vivo and in vitro experiments with rats, G. lucidum extract was quantitatively tested for its total polyphenol and/or flavonoid contents and ability to scavenge 2,2-diphenyl-1-picrylhydrazyl (DPPH)-free radicals. Chronic oral administration of G. lucidum extract (300 mg/kg BW) significantly decreased TNF-α and LPO levels in the gingival tissues of periodontitis model rats. G. lucidum extract also inhibited (P < 0.05) in vitro oxidative stress, as indicated by reduced levels of LPO in G. lucidum extract-preincubated gum tissue homogenates of fresh rats. The in vitro results were, thus, consistent with the in vivo inhibition of lipid peroxidation, DPPH free radical-scavenging effects, and the presence of total polyphenols/flavonoids in G. lucidum extract. Our results provide the evidence, at least partially, for the beneficial effects of G. lucidum on periodontitis, an inflammatory condition of gums which is associated with oxidative stress and preceded by infectious gum diseases.


Asunto(s)
Encía , Estrés Oxidativo , Periodontitis , Reishi , Factor de Necrosis Tumoral alfa , Animales , Estrés Oxidativo/efectos de los fármacos , Periodontitis/tratamiento farmacológico , Periodontitis/prevención & control , Factor de Necrosis Tumoral alfa/metabolismo , Reishi/química , Encía/efectos de los fármacos , Encía/metabolismo , Ratas , Masculino , Administración Oral , Modelos Animales de Enfermedad , Antioxidantes/farmacología , Antioxidantes/administración & dosificación , Ratas Wistar
3.
J Ovarian Res ; 17(1): 138, 2024 Jul 04.
Artículo en Inglés | MEDLINE | ID: mdl-38965577

RESUMEN

BACKGROUND: To investigate whether melatonin supplementation can enhance cardiometabolic risk factors, reduce oxidative stress, and improve hormonal and pregnancy-related factors in patients with PCOS. METHODS: We conducted a systematic search of PubMed/Medline, Scopus, and the Cochrane Library for articles published in English from inception to March 2023. We included randomized controlled trials (RCTs) on the use of melatonin for patients with polycystic ovary syndrome (PCOS). We performed a meta-analysis using a random-effects model and calculated the standardized mean differences (SMDs) and 95% confidence intervals (CIs). RESULTS: Six studies met the inclusion criteria. The result of meta-analysis indicated that melatonin intake significantly increase TAC levels (SMD: 0.87, 95% CI: 0.46, 1.28, I2 = 00.00%) and has no effect on FBS, insulin, HOMA-IR, TC, TG, HDL, LDL, MDA, hs-CRP, mFG, SHBG, total testosterone, and pregnancy rate in patients with PCOS compare to controls. The included trials did not report any adverse events. CONCLUSION: Melatonin is a potential antioxidant that may prevent damage from oxidative stress in patients with PCOS. However, the clear effect of melatonin supplementation on cardiometabolic risk factors, hormonal outcomes, and pregnancy-related outcomes needs to be evaluated further in large populations and long-term RCTs.


Asunto(s)
Factores de Riesgo Cardiometabólico , Suplementos Dietéticos , Melatonina , Estrés Oxidativo , Síndrome del Ovario Poliquístico , Ensayos Clínicos Controlados Aleatorios como Asunto , Humanos , Melatonina/farmacología , Melatonina/uso terapéutico , Síndrome del Ovario Poliquístico/tratamiento farmacológico , Síndrome del Ovario Poliquístico/sangre , Femenino , Estrés Oxidativo/efectos de los fármacos , Embarazo , Hormonas/sangre , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Antioxidantes/administración & dosificación
4.
Physiol Rep ; 12(13): e16095, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38946616

RESUMEN

The present study aimed to investigate the effect of catechin-loaded Chitosan-Alginate nanoparticles (NPs) on cognitive function in an aluminum chloride (AlCl3)-induced rat model of Alzheimer's disease (AD). The Catechin-loaded Chitosan-Alginate nanocarriers were synthesized through ionotropic gelation (IG) method. Physio-chemical characterization was conducted with the Zetasizer Nano system, the scanning electron microscope, and the Fourier transform infrared spectroscopy. The experiments were performed over 21 days on six groups of male Wistar rats. The control group, AlCl3 treated group, Catechin group, nanocarrier group, treatment group 1 (AlCl3 + Catechin), and treatment group 2 (AlCl3 + nanocarrier). A behavioral study was done by the Morris water maze (MWM) test. In addition, the level of oxidative indices and acetylcholine esterase (AChE) activity was determined by standard procedures at the end of the study. AlCl3 induced a significant increase in AChE activity, along with a significant decrease in the level of Catalase (CAT) and total antioxidant capacity (TAC) in the hippocampus. Moreover, the significant effect of AlCl3 was observed on the behavioral parameters of the MWM test. Both forms of Catechin markedly improved AChE activity, oxidative biomarkers, spatial memory, and learning. The present study indicated that the administration of Catechin-loaded Chitosan-Alginate NPs is a beneficial therapeutic option against behavioral and chemical alteration of AD in male Wistar rats.


Asunto(s)
Alginatos , Cloruro de Aluminio , Enfermedad de Alzheimer , Catequina , Quitosano , Nanopartículas , Ratas Wistar , Animales , Catequina/administración & dosificación , Catequina/farmacología , Cloruro de Aluminio/toxicidad , Quitosano/química , Quitosano/administración & dosificación , Alginatos/química , Alginatos/administración & dosificación , Masculino , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/inducido químicamente , Enfermedad de Alzheimer/metabolismo , Ratas , Administración Oral , Cognición/efectos de los fármacos , Acetilcolinesterasa/metabolismo , Aprendizaje por Laberinto/efectos de los fármacos , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Modelos Animales de Enfermedad , Antioxidantes/farmacología , Antioxidantes/administración & dosificación , Estrés Oxidativo/efectos de los fármacos , Portadores de Fármacos/química
5.
J Nippon Med Sch ; 91(3): 254-260, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38972737

RESUMEN

This review examines associations of nutrients and dietary preferences with recurrent pregnancy loss (RPL), miscarriage, and infertility. Research articles, reviews, and meta-analyses of RPL and infertility that focused on nutrition, meals, and lifestyle were reviewed, and associations of nutrients and dietary preferences with pregnancy are discussed in relation to recent research findings. Studies related to RPL were given the highest priority, followed by those dealing with miscarriage and infertility. Multivitamin supplements-even when lacking folic acid or vitamin A-reduced total fetal loss. High-dose folic acid supplementation before conception reduced the risk of miscarriage and stillbirth. A meta-analysis revealed a strong association of vitamin D deficiency/insufficiency with miscarriage. Another meta-analysis revealed that seafood and dairy products reduced the risk of miscarriage, whereas a caffeine intake of 300 mg/day or more was associated with miscarriage. A balanced diet that included nutrients with antioxidant properties helped prevent miscarriage, whereas a diet that included processed foods and nutrients with proinflammatory effects increased the risk of miscarriage. Associations of nutrients with RPL warrant further research.


Asunto(s)
Aborto Habitual , Dieta , Suplementos Dietéticos , Nutrientes , Humanos , Femenino , Aborto Habitual/prevención & control , Aborto Habitual/etiología , Embarazo , Nutrientes/administración & dosificación , Ácido Fólico/administración & dosificación , Infertilidad/etiología , Estilo de Vida , Riesgo , Antioxidantes/administración & dosificación , Vitaminas/administración & dosificación
6.
J Microencapsul ; 41(5): 390-401, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38945157

RESUMEN

Green-synthesis of biodegradable polymeric curcumin-nanoparticles using affordable biodegradable polymers to enhance curcumin's solubility and anti-oxidative potential. The curcumin-nanoparticle was prepared based on the ionic-interaction method without using any chemical surfactants, and the particle-size, zeta-potential, surface-morphology, entrapmentefficiency, and in-vitro drug release study were used to optimise the formulation. The antioxidant activity was investigated using H2DCFDA staining in the zebrafish (Danio rerio) model. The mean-diameter of blank nanoparticles was 178.2 nm (±4.69), and that of curcuminnanoparticles was about 227.7 nm (±10.4), with a PDI value of 0.312 (±0.023) and 0.360 (±0.02). The encapsulation-efficacy was found to be 34% (±1.8), with significantly reduced oxidative-stress and toxicity (∼5 times) in the zebrafish model compared to standard curcumin. The results suggested that the current way of encapsulating curcumin using affordable, biodegradable, natural polymers could be a better approach to enhancing curcumin's water solubility and bioactivity, which could further be translated into potential therapeutics.


Asunto(s)
Antioxidantes , Quitosano , Curcumina , Tecnología Química Verde , Goma Arábiga , Nanopartículas , Pez Cebra , Animales , Curcumina/farmacología , Curcumina/química , Curcumina/administración & dosificación , Curcumina/farmacocinética , Nanopartículas/química , Antioxidantes/farmacología , Antioxidantes/química , Antioxidantes/administración & dosificación , Quitosano/química , Goma Arábiga/química , Portadores de Fármacos/química , Liberación de Fármacos , Solubilidad , Estrés Oxidativo/efectos de los fármacos , Tamaño de la Partícula
7.
Int J Nanomedicine ; 19: 5441-5458, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38868593

RESUMEN

Introduction: Quercetin (QUER), a flavonoid abundant in fruits and vegetables, is emerging as a promising alternative therapeutic agent for obesity treatment due to its antioxidant and anti-adipogenic properties. However, the clinical application of QUER is limited by its poor solubility, low bioavailability, and potential toxicity at high doses. To address these challenges, this study aims to develop an advanced drug delivery system using fluorescent mesoporous silica nanoparticles (FMSNs) coated with polydopamine (PDA) for the efficient and sustained delivery of QUER to inhibit adipogenesis. Methods: The research included the synthesis of PDA-coated FMSNs for encapsulation of QUER, characterization of their mesoporous structures, and systematic investigation of the release behavior of QUER. The DPPH assay was used to evaluate the sustained radical scavenging potential. Concentration-dependent effects on 3T3-L1 cell proliferation, cellular uptake and adipogenesis inhibition were investigated. Results: PDA-coated FMSNs exhibited well-aligned mesoporous structures. The DPPH assay confirmed the sustained radical scavenging potential, with FMSNs-QUER@PDA showing 53.92 ± 3.48% inhibition at 72 h, which was higher than FMSNs-QUER (44.66 ± 0.57%) and free QUER (43.37 ± 5.04%). Concentration-dependent effects on 3T3-L1 cells highlighted the enhanced efficacy of PDA-coated FMSNs for cellular uptake, with a 1.5-fold increase compared to uncoated FMSNs. Adipogenesis inhibition was also improved, with relative lipid accumulation of 44.6 ± 4.6%, 37.3 ± 4.6%, and 36.5 ± 7.3% at 2.5, 5, and 10 µM QUER concentrations, respectively. Conclusion: The study successfully developed a tailored drug delivery system, emphasizing sustained QUER release and enhanced therapeutic effects. FMSNs, especially when coated with PDA, exhibit promising properties for efficient QUER delivery, providing a comprehensive approach that integrates advanced drug delivery technology and therapeutic efficacy.


Asunto(s)
Células 3T3-L1 , Adipogénesis , Preparaciones de Acción Retardada , Portadores de Fármacos , Indoles , Nanopartículas , Polímeros , Quercetina , Dióxido de Silicio , Quercetina/química , Quercetina/farmacología , Quercetina/farmacocinética , Quercetina/administración & dosificación , Animales , Ratones , Adipogénesis/efectos de los fármacos , Dióxido de Silicio/química , Indoles/química , Indoles/farmacología , Indoles/farmacocinética , Indoles/administración & dosificación , Nanopartículas/química , Preparaciones de Acción Retardada/química , Preparaciones de Acción Retardada/farmacología , Preparaciones de Acción Retardada/farmacocinética , Portadores de Fármacos/química , Polímeros/química , Porosidad , Liberación de Fármacos , Proliferación Celular/efectos de los fármacos , Antioxidantes/química , Antioxidantes/farmacología , Antioxidantes/farmacocinética , Antioxidantes/administración & dosificación
8.
Nutrients ; 16(11)2024 May 29.
Artículo en Inglés | MEDLINE | ID: mdl-38892600

RESUMEN

Obesity is an emerging threat and a current challenge for children and adolescents worldwide. The aim of the present work was to evaluate the relationship between the Dietary Antioxidant Index (DAI) and the weight status of students in early adolescence. A sample of 1580 students aged 10-12 years from 47 primary schools in Greece were enrolled. Anthropometric characteristics were assessed, and calculation of the Body Mass Index (BMI) was used to categorize students into two weight-status groups. Dietary habits and physical activity were evaluated using a self-completed questionnaire, and the DAI was calculated through derived micronutrients' content, along with energy, macro-, and micro-nutrient intake. Crude and adjusted regression analysis showed a significant inverse association of the DAI and body weight status (Odds Ratio (OR): 0.719, 95% Confidence Interval (CI): 0.576; 0.897, and adjusted Odds Ration (aOR): 0.667, 95% CI: 0.489; 0.907). An antioxidant diet seems to play a protective role against increased body weight among students in early adolescence. Thus, dietary patterns rich in antioxidants should be promoted to facilitate healthy habits early in life, and to fight the obesity threat.


Asunto(s)
Antioxidantes , Índice de Masa Corporal , Peso Corporal , Dieta , Estudiantes , Humanos , Masculino , Niño , Femenino , Antioxidantes/análisis , Antioxidantes/administración & dosificación , Grecia/epidemiología , Estudiantes/estadística & datos numéricos , Dieta/estadística & datos numéricos , Conducta Alimentaria , Instituciones Académicas , Obesidad Infantil/epidemiología , Obesidad Infantil/etiología , Ejercicio Físico , Estudios Transversales , Encuestas y Cuestionarios
9.
Nutrients ; 16(11)2024 May 30.
Artículo en Inglés | MEDLINE | ID: mdl-38892648

RESUMEN

Diabetic retinopathy (DR) is a major vision-threatening disease among the working-age population worldwide. Present therapeutic strategies such as intravitreal injection of anti-VEGF and laser photocoagulation mainly target proliferative DR. However, there is a need for early effective management in patients with early stage of DR before its progression into the more severe sight-threatening proliferative stage. Nutraceuticals, natural functional foods with few side effects, have been proposed to be beneficial in patients with DR. Over the decades, many studies, either in vitro or in vivo, have demonstrated the advantages of a number of nutraceuticals in DR with their antioxidative, anti-inflammatory, neuroprotective, or vasoprotective effects. However, only a few clinical trials have been conducted, and their outcomes varied. The low bioavailability and instability of many nutraceuticals have indeed hindered their utilization in clinical use. In this context, nanoparticle carriers have been developed to deliver nutraceuticals and to improve their bioavailability. Despite its preclinical nature, research of interventive nutraceuticals for DR may yield promising information in their clinical applications.


Asunto(s)
Retinopatía Diabética , Suplementos Dietéticos , Retinopatía Diabética/tratamiento farmacológico , Humanos , Antioxidantes/administración & dosificación , Disponibilidad Biológica , Sistemas de Liberación de Medicamentos , Animales , Antiinflamatorios/administración & dosificación
10.
PLoS One ; 19(6): e0304402, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38870164

RESUMEN

BACKGROUND: There is a consistent association between exposure to air pollution and elevated rates of cardiopulmonary illnesses. As public health activities emphasize the paramount need to reduce exposure, it is crucial to examine strategies like the antioxidant diet that could potentially protect individuals who are unavoidably exposed. METHODS: A systematic search was performed in PubMed/Medline, EMBASE, CENTRAL, and ClinicalTrials.gov up to March 31, 2023, for clinical trials assessing dietary supplements against cardiovascular (blood pressure, heart rate, heart rate variability, brachial artery diameter, flow-mediated dilation, and lipid profile) or pulmonary outcomes (pulmonary function and airway inflammation) attributed to air pollution exposure. RESULTS: After reviewing 4681 records, 18 studies were included. There were contradictory findings on the effects of fish oil and olive oil supplementations on cardiovascular outcomes. Although with limited evidence, fish oil offered protection against pulmonary dysfunction induced by pollutants. Most studies on vitamin C did not find protective cardiovascular effects; however, the combination of vitamin C and E offered protective effects against pulmonary dysfunction but showed conflicting results for cardiovascular outcomes. Other supplements like sulforaphane, L-arginine, n-acetylcysteine, and B vitamins showed potential beneficial effects but need further research due to the limited number of existing trials. CONCLUSIONS: Although more research is needed to determine the efficacy and optimal dose of anti-inflammatory and antioxidant dietary supplements against air pollution toxicity, this low-cost preventative strategy has the potential to offer protection against outcomes of air pollution exposure.


Asunto(s)
Contaminación del Aire , Suplementos Dietéticos , Humanos , Contaminación del Aire/efectos adversos , Antioxidantes/administración & dosificación , Enfermedades Cardiovasculares/prevención & control , Ensayos Clínicos como Asunto , Aceites de Pescado/administración & dosificación , Ácido Ascórbico/administración & dosificación
11.
Biol Pharm Bull ; 47(6): 1106-1112, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38839361

RESUMEN

Ultrafine bubbles (UFBs), which are bubbles with diameters of less than 1 µm, are widely recognized for their ability to exist stably in liquid as a result of the effects of Brownian motion. In this study, we focused on hydrogen, known for its antioxidant potential, and explored the function of H2-filled UFBs, which encapsulate hydrogen, to determine their potential use as oral carriers for the delivery bioactive gases to living organisms. To this end, rats were orally administered ethanol to induce hepatic oxidative stress, and the effects of drinking H2-filled UFBs (H2 NanoGAS®) water for two weeks were evaluated to assess the reduction of oxidative stress. Continuous alcohol consumption was found to significantly increase the blood lipid peroxidation levels in the control group, confirming the induction of oxidative stress. An increase in blood lipid peroxidation was significantly inhibited by the consumption of concentrated H2 NanoGAS® (C-HN) water. Furthermore, the measurement of mitochondrial activity in the liver revealed that drinking H2 NanoGAS® water helped to maintain at a normal level and/or boosted the functional activity of the electron transport system in mitochondria affected by ethanol intake. To our knowledge, this study is the first to provide evidence for the use of orally ingested UFBs as carriers for the delivery gases to tissues, thereby exerting their physiological activity in the body. Our findings highlight the potential for the application of UFBs to various physiologically active gases and their utilization in the medical field in the future.


Asunto(s)
Etanol , Hidrógeno , Peroxidación de Lípido , Hígado , Estrés Oxidativo , Animales , Estrés Oxidativo/efectos de los fármacos , Etanol/administración & dosificación , Hidrógeno/farmacología , Hidrógeno/administración & dosificación , Masculino , Peroxidación de Lípido/efectos de los fármacos , Hígado/metabolismo , Hígado/efectos de los fármacos , Administración Oral , Ratas , Ratas Wistar , Agua , Antioxidantes/farmacología , Antioxidantes/administración & dosificación
12.
Photodermatol Photoimmunol Photomed ; 40(4): e12985, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38845468

RESUMEN

BACKGROUND: Photoprotection is the first measure in the prevention and treatment of the deleterious effects that sunlight can cause on the skin. It is well known that prolonged exposure to solar radiation leads to acute and chronic complications, such as erythema, accelerated skin aging, proinflammatory and procarcinogenic effects, and eye damage, among others. METHODS: A better understanding of the molecules that can protect against ultraviolet radiation and their effects will lead to improvements in skin health. RESULTS: Most of these effects of the sunlight are modulated by oxidative stress and proinflammatory mechanisms, therefore, the supplementation of substances that can regulate and neutralize reactive oxygen species would be beneficial for skin protection. Current evidence indicates that systemic photoprotection should be used as an adjunctive measure to topical photoprotection. CONCLUSION: Oral photoprotectors are a promising option in improving protection against damage induced by UVR, as they contain active ingredients that increase the antioxidant effects of the body, complementing other photoprotection measures. We present a review of oral photoprotectors and their effects.


Asunto(s)
Sustancias Protectoras , Rayos Ultravioleta , Humanos , Administración Oral , Antioxidantes/administración & dosificación , Estrés Oxidativo/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Piel/metabolismo , Piel/efectos de la radiación , Piel/efectos de los fármacos , Luz Solar/efectos adversos , Rayos Ultravioleta/efectos adversos , Sustancias Protectoras/administración & dosificación
13.
Ulus Travma Acil Cerrahi Derg ; 30(6): 397-405, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38863293

RESUMEN

BACKGROUND: Wound healing involves the repair of skin and other soft tissues after an injury. Royal jelly, a product of bees, possesses antioxidant, anti-inflammatory, antibacterial, and antiviral properties. Melatonin, a circadian indoleamine, is produced in the pineal gland and other organs. This study explores the effects of melatonin and royal jelly, both individually and combined, on wound healing in geriatric and young mice. METHODS: The study includes 90 Balb/C mice divided into ten groups to assess the effects of royal jelly and melatonin on wound healing. Royal jelly was applied topically at a concentration of 300 mg/kg. Melatonin was formulated in a vaseline-based pomade at a concentration of 5 mg/kg. The substances were applied either separately or in combination to wounds created on the mice. RESULTS: Both substances significantly enhanced wound healing at a macroscopic level in both age groups. Melatonin was found to be more effective during the initial wound formation process, whereas royal jelly was more beneficial during the granulation phase. However, significant results at a histopathological level were observed only in geriatric animals. CONCLUSION: The findings suggest a potential new therapeutic approach to enhance wound healing, particularly in elderly individuals. However, these findings need to be supported through further research and clinical trials.


Asunto(s)
Ácidos Grasos , Melatonina , Ratones Endogámicos BALB C , Cicatrización de Heridas , Animales , Melatonina/farmacología , Melatonina/administración & dosificación , Melatonina/uso terapéutico , Cicatrización de Heridas/efectos de los fármacos , Ratones , Ácidos Grasos/administración & dosificación , Masculino , Modelos Animales de Enfermedad , Antioxidantes/farmacología , Antioxidantes/administración & dosificación , Heridas y Lesiones/tratamiento farmacológico , Heridas y Lesiones/patología
14.
Sci Rep ; 14(1): 12703, 2024 06 03.
Artículo en Inglés | MEDLINE | ID: mdl-38830913

RESUMEN

Studies on the beneficial role of dietary antioxidants in preventing or managing hypertension in postmenopausal women are infrequent. The present cross-sectional study aimed to assess the association between dietary antioxidants and hypertension among menopausal women in Rafsanjan, a city located in the southeast of Iran. This study was based on data from the Rafsanjan Cohort Study (RCS), as part of the Prospective Epidemiological Research Studies in IrAN (PERSIAN). Among 2359 postmenopausal women, finally, 1936 women were included in this study. Participants were grouped as having normal blood pressure (BP), elevated BP, stage 1 hypertension, or stage 2 hypertension as defined by the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) BP guideline. A food frequency questionnaire (FFQ), was utilized to ascertain the levels of various nutrients and dietary antioxidants in the diet. The association between dietary intakes of antioxidants and blood pressure groups was evaluated by crude and adjusted models in the multinominal logistics regression analysis. Normal BP, elevated BP, stage 1 hypertension, and stage 2 hypertension were observed in 35.69%, 3.62%, 10.59%, and 50.10% of postmenopausal women respectively. In the adjusted model, in subjects with higher consumption of ß-carotene, the odds ratios of elevated BP in the 3rd quartile was about 2 times (OR: 2.04 (1.06-3.93) higher than 1st quartile. Also, in subjects with medium quality of DAQS, the odds ratios of elevated BP and stage 1 blood pressure were about 2 times (OR: 2.09 (1.05-4.17) and 1.69 times (OR: 1.69 (1.09-2.63) higher than subjects with low quality respectively. Furthermore, we did not find any statistically significant association between increased intake of dietary antioxidants and decreased odds of hypertension. After controlling the effects of confounding variables, increased dietary intake of selenium, carotenoids, vitamin A, vitamin C, and vitamin E did not decrease the odds of hypertension in postmenopausal women. Accordingly, it is suggested that this association be further investigated in the follow-up phase of this prospective study.


Asunto(s)
Antioxidantes , Hipertensión , Humanos , Femenino , Hipertensión/epidemiología , Hipertensión/prevención & control , Antioxidantes/administración & dosificación , Persona de Mediana Edad , Irán/epidemiología , Estudios Transversales , Dieta , Posmenopausia , Presión Sanguínea , Estudios de Cohortes , Menopausia , Estudios Prospectivos , Anciano
15.
Brain Behav ; 14(6): e3599, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38873869

RESUMEN

BACKGROUND: Alzheimer's disease (AD) is a complex and common neurodegenerative disorder. The present study aimed to investigate the potential effects of selegiline (SEL) on various aspects of memory performance, anxiety, and oxidative stress in an AD rat model induced by intracerebroventricular injection of amyloid beta1-42 (Aß1-42). METHODS: Oral administration of SEL at a dose of 0.5 mg/kg/day was performed for 30 consecutive days. Following the 30 days, several tests, including the open-field, elevated plus-maze, novel object recognition, Morris water maze, and passive avoidance learning were conducted to assess locomotor activity, anxiety-like behavior, recognition memory, spatial memory, and passive avoidance memory, respectively. RESULTS: The results indicate that the induction of AD in rats led to recognition memory, spatial memory, and passive avoidance memory impairments, as well as increased anxiety. Additionally, the AD rats exhibited a decrease in total antioxidant capacity and an increase in total oxidant status levels, suggesting an imbalance in oxidative-antioxidant status. However, the administration of SEL improved memory performance, reduced anxiety, and modulated oxidative-antioxidant status in AD rats. CONCLUSIONS: These findings provide evidence that SEL may alleviate anxiety-like behavior and cognitive deficits induced by Aß through modulation of oxidative-antioxidant status.


Asunto(s)
Enfermedad de Alzheimer , Péptidos beta-Amiloides , Ansiedad , Trastornos de la Memoria , Estrés Oxidativo , Selegilina , Animales , Péptidos beta-Amiloides/metabolismo , Ansiedad/tratamiento farmacológico , Ansiedad/inducido químicamente , Ratas , Masculino , Selegilina/farmacología , Selegilina/administración & dosificación , Trastornos de la Memoria/tratamiento farmacológico , Trastornos de la Memoria/inducido químicamente , Estrés Oxidativo/efectos de los fármacos , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/inducido químicamente , Modelos Animales de Enfermedad , Reacción de Prevención/efectos de los fármacos , Fragmentos de Péptidos , Memoria Espacial/efectos de los fármacos , Aprendizaje por Laberinto/efectos de los fármacos , Ratas Wistar , Reconocimiento en Psicología/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Fármacos Neuroprotectores/administración & dosificación , Antioxidantes/farmacología , Antioxidantes/administración & dosificación
16.
ACS Appl Bio Mater ; 7(6): 3786-3795, 2024 Jun 17.
Artículo en Inglés | MEDLINE | ID: mdl-38828920

RESUMEN

Tannic acid (TA) possesses a notable ability to adhere to proline-rich proteins that make up skin cells and the extracellular matrix (ECM) in the skin tissue. Drug carriers with this specific adhesion ability exhibit improved drug delivery efficiency on the skin. Taking advantage of this, this study presents skin-adhesive TA-conjugated lipid nanovesicles (TANVs) for enhanced transdermal antioxidant delivery. We found that TANVs exhibited selective intermolecular interactions with keratinocyte proline-rich proteins (KPRPs) and collagen that makes up skin cells by hydrogen bonding and van der Waals interactions, further enabling the strong bonding to macroscopic skin itself and ECM. We used vitamin E (α-tocopherol), which is known to effectively reduce oxidative stress but has limited skin penetration, as a drug to verify improved in vitro delivery and therapeutic efficacy. The evaluation revealed that the antioxidant-loaded TANVs exerted excellent scavenging effects against reactive oxygen species induced by ultraviolet light or peroxides in the skin, thereby enabling the development of an active drug delivery system for dermal therapy.


Asunto(s)
Antioxidantes , Lípidos , Tamaño de la Partícula , Taninos , Antioxidantes/química , Antioxidantes/farmacología , Antioxidantes/administración & dosificación , Taninos/química , Animales , Lípidos/química , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Ensayo de Materiales , Humanos , Piel/metabolismo , Administración Cutánea , Portadores de Fármacos/química , Nanopartículas/química , Prolina/química , Especies Reactivas de Oxígeno/metabolismo , Polifenoles
17.
Int J Mol Sci ; 25(11)2024 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-38892359

RESUMEN

Transdermal drug delivery offers a promising alternative for administering medications like ibuprofen, known for its analgesic and anti-inflammatory properties, with reduced gastrointestinal side effects compared to oral administration. This study explored the potential synergistic effects of combining ibuprofen with lavender essential oil (LEO) in transdermal patches. The composition of LEO was analyzed, revealing predominant compounds such as linalyl acetate and linalool, which are known for their analgesic and anti-inflammatory properties. The physicochemical properties of the patches were investigated, indicating improved cohesion with the addition of LEO. Additionally, thermal stability assessments demonstrated enhanced stability with LEO incorporation with an increase in onset decomposition temperature from 49.0 to 67.9 °C. The antioxidant activity of patches containing LEO was significantly higher with a free radical scavenging ability of 79.13% RSA compared to 60% RSA in patches without LEO. Release and permeation studies showed that patches with LEO exhibited an increased permeation of ibuprofen through the skin with 74.40% of the drug released from LEO-containing patches compared to 36.29% from patches without LEO after 24 h. Moreover, the permeation rate was notably faster with LEO, indicating quicker therapeutic effects. The inclusion of LEO in transdermal patches containing ibuprofen holds promise for enhancing drug delivery efficiency and therapeutic effectiveness, offering a potential strategy for improved pain management with reduced side effects.


Asunto(s)
Antiinflamatorios , Ibuprofeno , Lavandula , Aceites Volátiles , Aceites de Plantas , Parche Transdérmico , Aceites Volátiles/química , Aceites Volátiles/farmacología , Aceites Volátiles/administración & dosificación , Lavandula/química , Aceites de Plantas/química , Aceites de Plantas/farmacología , Ibuprofeno/química , Ibuprofeno/administración & dosificación , Ibuprofeno/farmacología , Antiinflamatorios/farmacología , Antiinflamatorios/química , Antiinflamatorios/administración & dosificación , Administración Cutánea , Animales , Antioxidantes/química , Antioxidantes/farmacología , Antioxidantes/administración & dosificación , Liberación de Fármacos , Monoterpenos Acíclicos , Monoterpenos
18.
PLoS One ; 19(6): e0306038, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38924041

RESUMEN

BACKGROUND: The dual existence of Type 2 Diabetes Mellitus (T2DM) and obesity within a single individual may describe a combined adverse health effects, including impaired quality of life and increased risk for cardiovascular diseases (CVDs). Oxidative stress is a contributing factor to the pathogenesis of obesity. Meanwhile, dietary antioxidants may improve the antioxidant defense system and thereby decrease oxidative injury. Dietary total antioxidant capacity (TAC) is usually used to investigate the potential health effects of dietary antioxidant intake on several oxidative stress induced chronic diseases. This study aimed to examine the association of dietary TAC with obesity-related features in T2DM patients. METHODS: The present study included 254 type 2 diabetes outpatients with a mean (SD) age of 54.52 (7.21) years and mean (SD) diabetes duration of 8.2 (6.4) years. Data on dietary intake was assessed using a validated food frequency questionnaire. Dietary TAC was estimated by ferric reducing antioxidant potential (FRAP) method. Anthropometric, clinical and lifestyle characteristics were all collected. RESULTS: In linear regression analyses, dietary antioxidant capacity was inversely associated with body mass index (ß = -0,231; 95% CI, -0,419 to -0,042), waist circumference (ß = -0,427; 95% CI, -0,849 to -0,006) and fat mass percentage (ß = -0,328; 95% CI, -0,545 to -0,112) independently of the assessed confounding variables. Interestingly, dietary TAC showed positive and significant associations with vitamin A, vitamin C, ß-carotene, magnesium, folic acid and iron intakes, after adjusting for age and daily energy intake. CONCLUSIONS: Higher intake of dietary TAC was in association with lower indices of general and central obesity in T2DM patients. Therefore, dietary recommendations for counteracting obesity in patients with T2DM should take into account a high dietary TAC.


Asunto(s)
Antioxidantes , Diabetes Mellitus Tipo 2 , Obesidad Abdominal , Humanos , Diabetes Mellitus Tipo 2/dietoterapia , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/metabolismo , Persona de Mediana Edad , Antioxidantes/metabolismo , Antioxidantes/administración & dosificación , Femenino , Masculino , Obesidad Abdominal/complicaciones , Dieta , Índice de Masa Corporal , Estrés Oxidativo/efectos de los fármacos , Obesidad/metabolismo , Obesidad/complicaciones , Obesidad/dietoterapia , Circunferencia de la Cintura , Adulto
19.
AAPS PharmSciTech ; 25(6): 145, 2024 Jun 25.
Artículo en Inglés | MEDLINE | ID: mdl-38918292

RESUMEN

The objective of the current research was to develop abietic acid (AA)-loaded hybrid polymeric nanoparticles (HNPs) for anti-inflammatory and antioxidant activity after oral administration. AAHNPs were developed by microinjection technique and optimized by 3-factor 3-level Box-Behnken design. The AAHNPs were evaluated for morphology, FTIR, X-ray diffraction, in-vitro release, ex-vivo permeation, in-vitro antioxidant, and in-vivo anti-inflammatory activity. The optimized AAHNPs (AAHNPsopt) displayed 384.5 ± 6.36nm of PS, 0.376 of PDI, 23.0 mV of ZP, and 80.01 ± 1.89% of EE. FTIR and X-ray diffraction study results revealed that AA was encapsulated into a HNPs matrix. The AAHNPsopt showed significant (P < 0.05) high and sustained release of AA (86.72 ± 4.92%) than pure AA (29.87 ± 3.11%) in 24h. AAHNPsopt showed an initial fast release of AA (20.12 ± 3.07% in 2h), which succeeded in reaching the therapeutic concentration. The AAHNPsopt showed 2.49-fold higher ex-vivo gut permeation flux than pure AA due to the presence of lipid and surfactant. The AAHNPsopt exhibited significantly (P < 0.05, P < 0.01, P < 0.001) higher antioxidant activity as compared to pure AA at each concentration. AAHNPsopt formulation displayed a significantly (P < 0.05) higher anti-inflammatory effect (21.51 ± 2.23% swelling) as compared to pure AA (46.51 ± 1.74% swelling). From the in-vitro and in-vivo finding, it was concluded that HNPs might be a suitable carrier for the improvement of the therapeutic efficacy of the drug.


Asunto(s)
Abietanos , Antiinflamatorios , Antioxidantes , Portadores de Fármacos , Lípidos , Nanopartículas , Polímeros , Nanopartículas/química , Animales , Antioxidantes/farmacología , Antioxidantes/química , Antioxidantes/administración & dosificación , Antioxidantes/farmacocinética , Ratas , Polímeros/química , Antiinflamatorios/farmacología , Antiinflamatorios/química , Antiinflamatorios/administración & dosificación , Antiinflamatorios/farmacocinética , Lípidos/química , Portadores de Fármacos/química , Abietanos/farmacología , Abietanos/administración & dosificación , Abietanos/química , Difracción de Rayos X/métodos , Liberación de Fármacos , Administración Oral , Masculino , Tamaño de la Partícula , Ratas Wistar , Química Farmacéutica/métodos
20.
Medicina (Kaunas) ; 60(6)2024 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-38929497

RESUMEN

Background and Objectives: Genitourinary syndrome, previously defined as vulvovaginal atrophy, manifests with signs and symptoms deriving from estrogen diminution in the female genitourinary tract. Stable ozonides are derivatives of artemisinin found to be stable against strong basic and acidic conditions. Vitamin E is an important antioxidant diminishing the output of reactive oxygen species in the oxidation of fats and the emanation of free radicals, reducing cellular injury and aging. The primary aim of the present study was to assess the positive effects of an ozonide plus a vitamin E acetate-based compound (Ozoile) on genitourinary syndrome symptom relief after a maximum of 20 days of treatment. Materials and Methods: The inclusion criteria for patients' enrollment were women of child-bearing age or in menopause reporting genitourinary syndrome's related symptoms, such as pain, burning, a bad smell, dyspareunia, dryness, itching, bleeding, and nervousness. The exclusion criteria were Sjogren's syndrome and patients administered retinoic acid, an agent that causes mucosal dryness. Participants completed a questionnaire before and after 20 days of treatment. Results: The incidence of pain decreased from 16.7% to 11.8% (p-value < 0.0001). In addition, the mean symptom intensity decreased from 2.10 to 0.87 (p-value < 0.0001). Dryness was the most frequent pre-treatment symptom and decreased from 85.5% to 53.8% (p-value < 0.0001) (mean: 2.21 vs. 0.90; p-value < 0.0001). Conclusions: Ozoile was effective in reducing most gynecologic symptoms related to genitourinary syndrome. However, further studies are needed to compare its effect with other standards of care.


Asunto(s)
Vitamina E , Humanos , Femenino , Persona de Mediana Edad , Adulto , Síndrome , Vitamina E/uso terapéutico , Vitamina E/administración & dosificación , Antioxidantes/uso terapéutico , Antioxidantes/administración & dosificación , Enfermedades Urogenitales Femeninas/tratamiento farmacológico , Atrofia/tratamiento farmacológico , Anciano , Encuestas y Cuestionarios , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...